Galcanezumab

FDA Drug Profile

Drug Details

Generic Name
Galcanezumab
Brand Names
N/A
Application Number
Sponsor
ImClone Systems LLC
NDC Codes
1
Dosage Forms
SOLUTION
Routes
N/A
Active Ingredients
GALCANEZUMAB

Indications and Usage

1 INDICATIONS AND USAGE EMGALITY ® is a calcitonin-gene related peptide antagonist indicated in adults for the: preventive treatment of migraine. ( 1.1 ) treatment of episodic cluster headache. ( 1.2 ) 1.1 Migraine EMGALITY is indicated for the preventive treatment of migraine in adults. 1.2 Episodic Cluster Headache EMGALITY is indicated for the treatment of episodic cluster headache in adults.